Failure of asparagine (ASN) depletion, not inadequate asparaginase (ASNase) activity, predicts relapse in standard risk (SR) childhood acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) report

被引：3
|
作者：
Avramis, Vassilios I. [1 ]
Holcenberg, John S. [1 ]
Ettinger, Alice G. [1 ]
Stork, Linda C. [1 ]
La, Mei [1 ]
Gaynon, Paul S. [1 ]
机构：
[1] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.588.588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
588
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [41] Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)
    Hardy, Kristina K.
    Embry, Leanne
    Kairalla, John A.
    Sharkey, Christina
    Gioia, Anthony R.
    Griffin, Danielle
    Berger, Carly
    Weisman, Hannah S.
    Noll, Robert B.
    Winick, Naomi J.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (11)
  • [42] Association of intravenous (IV) and intramuscular (IM) pegaspargase (PEG) administration with rate of adverse events (AE) in standard risk (SR) Acute Lymphoblastic Leukemia (ALL) Children's Oncology Group (COG) trials.
    Maloney, Kelly W.
    Angiolillo, Anne L.
    Schore, Reuven J.
    Devidas, Meenakshi
    Lu, Xiaomin
    Wang, Cindy
    Friedmann, Alison M.
    Mattano, Leonard A.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Stork, Linda C.
    Winick, Naomi J.
    Hunger, Stephen
    Carroll, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) study.
    Rheingold, Susan R.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Brown, Patrick A.
    Gore, Lia
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Bhojwani, Deepa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Weight Change During Childhood Acute Lymphoblastic Leukemia Induction Therapy Predicts Obesity: A Report From the Children's Oncology Group
    Withycombe, Janice S.
    Smith, Lynette M.
    Meza, Jane L.
    Merkle, Carrie
    Faulkner, Melissa Spezia
    Ritter, Leslie
    Seibel, Nita L.
    Moore, Ki
    PEDIATRIC BLOOD & CANCER, 2015, 62 (03) : 434 - 439
  • [45] Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)
    Sumit Gupta
    Meenakshi Devidas
    Mignon L. Loh
    Elizabeth A. Raetz
    Si Chen
    Cindy Wang
    Patrick Brown
    Andrew J. Carroll
    Nyla A. Heerema
    Julie M. Gastier-Foster
    Kimberly P. Dunsmore
    Eric C. Larsen
    Kelly W. Maloney
    Leonard A. Mattano
    Stuart S. Winter
    Naomi J. Winick
    William L. Carroll
    Stephen P. Hunger
    Michael J. Borowitz
    Brent L. Wood
    Leukemia, 2018, 32 : 1370 - 1379
  • [46] Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)
    Gupta, Sumit
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Chen, Si
    Wang, Cindy
    Brown, Patrick
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Dunsmore, Kimberly P.
    Larsen, Eric C.
    Maloney, Kelly W.
    Mattano, Leonard A., Jr.
    Winter, Stuart S.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    Borowitz, Michael J.
    Wood, Brent L.
    LEUKEMIA, 2018, 32 (06) : 1370 - 1379
  • [47] Efficacy and safety of intramuscular (IM) recombinant Erwinia asparaginase in acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): The Children's Oncology Group (COG) AALL1931 study.
    Maese, Luke Devon
    Loh, Mignon L.
    Choi, L. Mi Rim
    Lin, Tong
    Aoki, Etsuko
    Zanette, Michelle
    Agarwal, Shirali
    Silverman, Jeffrey Alan
    Silverman, Lewis B.
    Raetz, Elizabeth A.
    Rau, Rachel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Outcomes of Patients with Down Syndrome and CRLF2-Overexpressing Acute Lymphoblastic Leukemia (ALL): A Report from the Children's Oncology Group (COG)
    Rabin, Karen R.
    Devidas, Meenakshi
    Chen, Zhiguo
    Dai, Yunfeng
    Tasian, Sarah K.
    Hitzler, Johann K.
    Roberts, Kathryn G.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Borowitz, Michael J.
    Wood, Brent L.
    Mullighan, Charles G.
    Harvey, Richard C.
    Chen, I-Ming L.
    Willman, Cheryl L.
    Reshmi, Shalini C.
    Gastier-Foster, Julie M.
    Maloney, Kelly W.
    Larsen, Eric C.
    Schore, Reuven J.
    Burke, Michael J.
    Salzer, Wanda L.
    Winick, Naomi J.
    Carroll, William L.
    Raetz, Elizabeth A.
    Angiolillo, Anne
    Loh, Mignon L.
    Hunger, Stephen P.
    BLOOD, 2020, 136
  • [49] Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report
    Wadhwa, Aman
    Chen, Yanjun
    Hageman, Lindsey
    Hoppmann, Anna
    Angiolillo, Anne
    Dickens, David S.
    Neglia, Joseph P.
    Ravindranath, Yaddanapudi
    Ritchey, A. Kim
    Termuhlen, Amanda
    Wong, F. Lennie
    Landier, Wendy
    Bhatia, Smita
    BLOOD, 2023, 142 (03) : 221 - 229
  • [50] Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's oncology group study CCG-1952
    Malempati, Suman
    Gaynon, Paul S.
    Sather, Harland
    La, Mei K.
    Stork, Linda C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (36) : 5800 - 5807
12345